Abstract
OBJECTIVE. CT remains the imaging modality of choice in the diagnosis of colorectal cancer (CRC) and anal cancer. However, advances in imaging have expanded the role of MRI and PET/CT. This article focuses on the evolving role of FDG PET/CT in the diagnosis, radiation therapy planning, therapy assessment, and posttherapy monitoring of CRC and anal cancer. CONCLUSION. FDG PET/CT is a valuable imaging modality that impacts the clinical management of patients with CRC and those with anal cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 1109-1119 |
Number of pages | 11 |
Journal | American Journal of Roentgenology |
Volume | 203 |
Issue number | 5 |
DOIs | |
State | Published - Nov 1 2014 |
Keywords
- Anal cancer
- Colorectal cancer
- PET/CT
- Radiation therapy planning
- Therapy assessment
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging